Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BACK

IMAC Holdings Inc

Mar 14 • 04:00PM ET

0.5690

Dollar change -0.0325
Percentage change -5.40	%

Healthcare • Medical Care Facilities • USA • NASD

Peers: AXNX PTGX ADUS ESTA EOLS HROW BLFS AXGN NAOV SMLR

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	3.62%	Shs Outstand	3.37M	Perf Week	1.61%
Market Cap	1.91M	Forward P/E	-	EPS next Y	-	Insider Trans	262.99%	Shs Float	3.24M	Perf Month	-6.72%
Income	-	PEG	-	EPS next Q	-	Inst Own	1.46%	Short Float	4.18%	Perf Quarter	-52.58%
Sales	-	P/S	-	EPS this Y	-	Inst Trans	78.36%	Short Ratio	0.09	Perf Half Y	-64.21%
Book/sh	-2.38	P/B	-	EPS next Y	-	ROA	-	Short Interest	0.14M	Perf Year	-60.76%
Cash/sh	0.06	P/C	9.55	EPS next 5Y	-	ROE	-	52W Range	0.47 - 7.75	Perf YTD	-55.20%
Dividend Est.	-	P/FCF	-	EPS past 5Y	10.09%	ROI	-	52W High	-92.66%	Beta	1.20
Dividend TTM	-	Quick Ratio	0.08	Sales past 5Y	-25.77%	Gross Margin	-	52W Low	21.06%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	0.08	EPS Y/Y TTM	14.37%	Oper. Margin	-	RSI (14)	41.12	Volatility	8.44% 9.01%
Employees	4	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	8.25
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	-8.76%	Payout	-	Rel Volume	0.09	Prev Close	0.60
Sales Surprise	-	EPS Surprise	61.54%	Sales Q/Q	-95.81%	Earnings	-	Avg Volume	1.48M	Price	0.57
SMA20	-6.52%	SMA50	-31.72%	SMA200	-58.98%	Trades		Volume	130,776	Change	-5.40%

Feb-24-25 08:15AM	Ignite Proteomics to Present Data on MHC-II as a Predictor of Pembrolizumab Response at NCCN Annual Conference (GlobeNewswire)
Feb-19-25 09:15AM	Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay (GlobeNewswire)
Feb-10-25 09:15AM	Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response (GlobeNewswire) -8.34%
Jan-27-25 04:10PM	IMAC Holdings Introduces Ignite Proteomics: A New Standard for Matching Patients with the Right Cancer Therapies (GlobeNewswire) +12.80% +47.17%
Nov-22-24 05:15PM	IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q (GlobeNewswire)
09:10AM	Loading…
Nov-14-24 09:10AM	IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1) (GlobeNewswire)
Sep-19-24 10:00AM	IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology (GlobeNewswire)
Aug-23-24 05:20PM	IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q (GlobeNewswire)
Jul-11-24 09:21AM	IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors (GlobeNewswire)
Jul-02-24 07:40AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Jun-25-24 09:00AM	DayDayCook Names Jeffrey Ervin as Co-Chief Financial Officer (GlobeNewswire)
Jun-03-24 09:53AM	BACK Stock Earnings: IMAC Holdings Reported Results for Q1 2024 (InvestorPlace)
May-24-24 09:00AM	IMAC Holdings Announces Leadership Succession (GlobeNewswire) +10.26%
May-07-24 08:30AM	IMAC Holdings Acquires Assets of Theralink to Continue Precision Medicine Business (GlobeNewswire)
Apr-18-24 08:27AM	3 Short-Squeeze Stocks to Buy for 100% Returns in Q2 2024 (InvestorPlace) -12.68%
06:45AM	Loading…
Feb-13-24 06:45AM	Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors (GlobeNewswire)
Nov-13-23 02:15PM	Theralink and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4 (GlobeNewswire) +5.78%
Nov-03-23 09:15AM	Theralink Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute's Molecular Tumor Board (GlobeNewswire) -9.49%
Oct-04-23 09:15AM	Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023 (GlobeNewswire)
Sep-27-23 04:30PM	IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Sep-07-23 12:45PM	IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split (GlobeNewswire) +7.66%
Jul-27-23 02:08PM	If You Can Only Buy One Penny Stock, It Better Be One of These 3 Names (InvestorPlace) -5.24%
Jul-26-23 09:25AM	IMAC Holdings Announces $4.3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market (GlobeNewswire)
Jun-28-23 04:30PM	IMAC Holdings Annual Meeting of Shareholders Reminder (GlobeNewswire)
Jun-27-23 09:20AM	Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer (GlobeNewswire)
May-23-23 09:43AM	Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company (GlobeNewswire) +12.83%
Apr-19-23 02:09PM	IMAC Holdings, Inc.'s (NASDAQ:BACK) Prospects Need A Boost To Lift Shares (Simply Wall St.) -6.47%
Mar-31-23 08:00PM	IMAC Holdings Reports Year End 2022 Financial Results and Corporate Update (GlobeNewswire) -7.20%
Mar-20-23 07:30AM	IMAC Holdings and Brain Scientific Announce a Strategic Merger to Create Synergistic End-To-End Neurological Solution (GlobeNewswire) +5.43%
Mar-01-23 09:30AM	IMAC Holdings, Inc announces the sale of The BackSpace (GlobeNewswire) -6.38%
05:38AM	Loading…
Nov-17-22 05:38AM	IMAC Holdings Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.)
Nov-15-22 06:00AM	IMAC Holdings Announces Third Quarter Results (GlobeNewswire) -13.19%
Nov-03-22 08:30AM	IMAC Holdings, Inc. Launches E-Commerce Website for Vitamin and Supplement Line (GlobeNewswire)
Oct-21-22 10:30AM	IMAC Holdings, Inc. Hosts Hall of Fame Athlete Panel at the Evoke Conference to Launch Whole Food Supplement Partnership (GlobeNewswire)
Sep-09-22 09:22AM	IMAC Holdings, Inc. Announces Completion of Third Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinsons Disease (GlobeNewswire) +5.20%
Sep-07-22 08:30AM	Biote Announces Strategic Partnership with IMAC Holdings, Inc. (GlobeNewswire) +8.89%
Sep-01-22 09:44AM	IMAC Holdings, Inc. Announces Addition of Medical Weight Loss Services to IMAC Regeneration Centers (GlobeNewswire)
Aug-16-22 04:00PM	IMAC Holdings, Inc. Announces Closing of $3.9 Million Registered Direct and Private Placement Offerings (GlobeNewswire) -6.45%
Aug-15-22 11:30AM	IMAC Holdings Reports Record Revenue of $5M in Second Quarter (GlobeNewswire)
Aug-12-22 09:16AM	IMAC Holdings, Inc. Announces $3.9 Million Registered Direct and Private Placement (GlobeNewswire) -33.36%
Aug-10-22 08:30AM	IMAC Holdings, Inc. Adds Stretch Services at The BackSpace (GlobeNewswire)

IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. Its services include medical treatments, regenerative medicine, physical medicine, physical therapy, spinal decompression and chiropractic manipulation. The company was founded by Matthew C. Wallis, Jason William Brame and Jeffrey S. Ervin in August 2000 and is headquartered in Franklin, TN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ruiz Jorge	10% Owner	Mar 25 '24	Sale	2.45	2,156	5,273	146,229	Mar 14 05:37 PM
Ruiz Jorge	10% Owner	Mar 22 '24	Buy	3.58	164,872	590,192	164,872	Mar 14 03:43 PM
Ruiz Jorge	10% Owner	Mar 22 '24	Sale	2.42	16,487	39,955	148,385	Mar 14 03:43 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BACK

IMAC Holdings Inc

Upgrade your FINVIZ experience